Boston, July 07, 2025 (GLOBE NEWSWIRE) — BCC Research announces the release of its 2024 DNA and RNA Synthesis Research Review, offering detailed insights into the markets shaping genetic research and biotechnology. This review highlights the market growth trends, emerging technologies, and clinical applications that are transforming the field of synthetic biology and personalized medicine.
The report underscores the expanding role of DNA and RNA synthesis technologies in healthcare, diagnostics, therapeutics, and research innovation.
Key Highlights:
- DNA Sequencing Market:
- The market is projected to grow from $14.8 billion in 2024 to $34.8 billion by the end of 2029.
- Compound Annual Growth Rate (CAGR): 18.6%.
- Next-Generation Sequencing Market in Clinical Application:
- The market is projected to grow from $21.9 billion in 2023 to $52.9 billion by the end of 2028.
- CAGR: 19.3%.
- RNA Sequencing Market:
- The market is projected to grow from $4.3 billion in 2024 to $10.3 billion by the end of 2029.
- CAGR: 19.1%.
Research Coverage and Insights:
The 2024 DNA and RNA Synthesis Research Review explores the growing role of synthetic DNA and RNA in biotechnology, medicine, and research. It highlights advances in drug development, gene therapy, and molecular diagnostics, shaping the future of healthcare …